Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Stretch Mark

Kineta Acquires Novel Drug Candidates From Airmid For Potential Treatment Of Multiple Sclerosis, Type 1 Diabetes And Other Autoimmune Diseases
Kineta, Inc. of Seattle and Airmid Incorporated of Redwood City, CA jointly announce an agreement in which a Kineta subsidiary has acquired exclusive commercial rights to a portfolio of novel therapeutic compounds from Airmid. The array of compounds holds extraordinary potential for the treatment of multiple sclerosis, type 1 diabetes mellitus and numerous other autoimmune diseases.
generic viagra online
New Test From Quest Diagnostics Helps Physicians Choose HIV Antiretroviral Therapy In Patients With History Of Drug Resistance
Quest Diagnostics Incorporated (NYSE: DGX), the world"s leading provider of diagnostic testing, information and services, today announced the availability of a new laboratory developed test designed to help physicians determine whether a patient with a history of HIV drug resistance will respond to the latest class of HIV antiretroviral therapies. The HIV-1 Coreceptor Tropism Test, which reports results in approximately half the time of the nearest competing test, provides physicians with timely information so they may more quickly determine or change therapy based on how the HIV virus infects cells in the individual patient.
News of the day
Inviragen Researching Vaccines To Protect Against Pandemic And Seasonal Influenza Viruses
Based on its ongoing avian influenza vaccine research, Inviragen is designing vaccines to protect against multiple influenza strains, including seasonal influenza and the recently emerged H1N1 influenza strain. The H1N1 influenza virus has caused nearly 30,000 cases worldwide in 74 countries leading to 144 deaths. In contrast, while no H5N1 avian influenza strain capable of human-to-human transmission has yet emerged, the high mortality of the virus represents a threat for future epidemics. In addition, conventional seasonal influenza continues to impact public health, causing an estimated 250,000 deaths worldwide every year. Inviragen will leverage its success in designing avian influenza vaccines to identify vaccine candidates that protect against pandemic and seasonal influenza viruses.
Oncology

WHO, UNICEF Say Vitamin A, Deworming Interventions Safe, In Response To Alleged Deaths, Sickness In Bangladesh

The WHO and UNICEF on Tuesday said that vitamin A supplements and deworming tablets are safe, after two deaths and the "sickness of hundreds" were alleged among the children who received the interventions during a nationwide campaign in Bangladesh, Bernama.com reports (Bernama.com, 6/9). Bangladesh"s Institute of Public Health and Nutrition distributed vitamin A capsules to 20 million children under age five in an effort to prevent childhood blindness and reduce death, IRIN reports. Nineteen million children between the ages of two and five received deworming tablets, according to health officials (IRIN, 6/8). Just days after the campaign, illness was reported in several districts around the country. According to the Daily Star, "Panic gripped the parents" of children who took vitamin A supplements and deworming tablets, which were manufactured by a Canadian company (Daily Star, 6/8). Health Ministry Forms Committee To Investigate Sickness In response to the cases of illness, the health ministry has formed a five-member committee to examine why so many children became sick after the campaign, bdnews24.com reports. ABM Jahangir Alam, a director of primary healthcare services of the health directorate, is leading the committee, which was asked to submit a report within a day or two. AFM Ruhal Haque, Bangladesh"s health minister, said that the vitamin A drive has been running for more than three decades has always been "effective and successful" and "has never created any apprehension of harm to children." He added that deworming campaigns had also never caused harm (bdnews24.com, 6/8). In a statement, he said the vitamin A capsules were WHO-certified and that the capsules were set to expire in 2012. He said the deworming tablets were supplied by UNICEF and were due to expire in 2010 (Xinhua, 6/8). The WHO and UNICEF "are fully confident about the actions taken by the (Bangladeshi) government to investigate the cases of children allegedly becoming sick after taking Vitamin A capsules and deworming tablets," according to a joint statement from the U.N. agencies (Bernama.com, 6/9). This information was reprinted from globalhealth.kff.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives and sign up for email delivery at globalhealth.kff.org. © Henry J. Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009